or Try an Advanced Search...

    Technical Analysis for HLS - HLS Therapeutics Inc

    Grade Last Price % Change Price Change
    A 4.920 0.61% 0.030
    HLS closed up 0.61 percent on Thursday, April 18, 2024, on 5 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
    Earnings due: May 9
    *** please verify all earnings dates ***
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Up Up Flat
    Historical HLS trend table...
    Date Alert Name Type % Chg
    1,2,3 Pullback Bullish Bullish Swing Setup 0.00%
    180 Bullish Setup Bullish Swing Setup 0.00%
    Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
    NR7 Range Contraction 0.00%
    NR7-2 Range Contraction 0.00%
    Narrow Range Bar Range Contraction 0.00%
    Inside Day Range Contraction 0.00%
    Wide Bands Range Expansion 0.00%
    NR7 Range Contraction 0.61%
    Narrow Range Bar Range Contraction 0.61%
    Older End-of-Day Signals for HLS ...

       Recent Intraday Alerts

    Alert Time
    Fell Below Previous Day's Low 3 days ago
    Down 1% 3 days ago
    Possible Inside Day 3 days ago
    Possible NR7 3 days ago
    Up 1% 3 days ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    HLS Chart by TradingView
    Basic chart:

    Profile

    HLS Therapeutics Inc., a specialty pharmaceutical company, acquires and commercializes pharmaceutical products in the specialty central nervous system and cardiovascular markets in Canada, the United States, and internationally. Its lead product is Clozaril, an atypical antipsychotic used in the treatment of schizophrenia. The company also holds the U.S. marketing rights of Absorica, a commercial stage dermatology product. HLS Therapeutics Inc. has a license agreement with Amarin Corporation plc to register, commercialize, and distribute Vascepa capsules in Canada. The company was founded in 2018 and is headquartered in Toronto, Canada.
    Classification
    Sector: Healthcare
    Industry: Drug Manufacturers - Specialty & Generic
    Keywords: Pharmaceutical Life Sciences Pharmaceutical Products Schizophrenia

    Is HLS a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 7.12
    52 Week Low 3.34
    Average Volume 11,717
    200-Day Moving Average 4.700
    50-Day Moving Average 4.227
    20-Day Moving Average 4.392
    10-Day Moving Average 4.898
    Average True Range 0.233
    RSI (14) 63.10
    ADX 40.69
    +DI 44.530
    -DI 12.373
    Chandelier Exit (Long, 3 ATRs) 4.781
    Chandelier Exit (Short, 3 ATRs) 4.219
    Upper Bollinger Bands 5.495
    Lower Bollinger Band 3.288
    Percent B (%b) 0.74
    BandWidth 50.243
    MACD Line 0.264
    MACD Signal Line 0.201
    MACD Histogram 0.0623
    Fundamentals Value
    Market Cap 156.57 Million
    Num Shares 31.8 Million
    EPS -0.90
    Price-to-Earnings (P/E) Ratio -5.48
    Price-to-Sales 8.55
    Price-to-Book 2.89
    Dividend 0.16
    Dividend Yield 3.25%
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 4.950
    Resistance 3 (R3) 4.947 4.933 4.945
    Resistance 2 (R2) 4.933 4.926 4.935 4.943
    Resistance 1 (R1) 4.927 4.921 4.930 4.930 4.942
    Pivot Point 4.913 4.913 4.915 4.915 4.913
    Support 1 (S1) 4.907 4.906 4.910 4.910 4.898
    Support 2 (S2) 4.893 4.901 4.895 4.897
    Support 3 (S3) 4.887 4.893 4.895
    Support 4 (S4) 4.890